Literature DB >> 26949083

Phase variation of Opa proteins of Neisseria meningitidis and the effects of bacterial transformation.

Manish Sadarangani1, Claire J Hoe, Katherine Makepeace, Peter van der Ley, Andrew J Pollard.   

Abstract

Opa proteins are major proteins involved in meningococcal colonization of the nasopharynx and immune interactions. Opa proteins undergo phase variation (PV) due to the presence of the 5'-CTCTT-3' coding repeat (CR) sequence. The dynamics of PV of meningococcal Opa proteins is unknown. Opa PV, including the effect of transformation on PV, was assessed using a panel of Opa-deficient strains of Neisseria meningitidis. Analysis of Opa expression from UK disease-causing isolates was undertaken. Different opa genes demonstrated variable rates of PV, between 6.4 × 10(-4) and 6.9 × 10(-3) per cell per generation. opa genes with a longer CR tract had a higher rate of PV (r(2) = 0.77, p = 0.1212). Bacterial transformation resulted in a 180-fold increase in PV rate. The majority of opa genes in UK disease isolates (315/463, 68.0%) were in the 'on' phase, suggesting the importance of Opa proteins during invasive disease. These data provide valuable information for the first time regarding meningococcal Opa PV. The presence of Opa PV in meningococcal populations and high expression of Opa among invasive strains likely indicates the importance of this protein in bacterial colonization in the human nasopharynx. These findings have potential implications for development of vaccines derived from meningococcal outer membranes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26949083     DOI: 10.1007/s12038-016-9588-y

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  38 in total

1.  Mutator clones of Neisseria meningitidis in epidemic serogroup A disease.

Authors:  Anthony R Richardson; Zhong Yu; Tanja Popovic; Igor Stojiljkovic
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

Review 2.  Opa proteins and CEACAMs: pathways of immune engagement for pathogenic Neisseria.

Authors:  Manish Sadarangani; Andrew J Pollard; Scott D Gray-Owen
Journal:  FEMS Microbiol Rev       Date:  2011-01-17       Impact factor: 16.408

3.  Phase variation mediates reductions in expression of surface proteins during persistent meningococcal carriage.

Authors:  Mohamed Alamro; Fadil A Bidmos; Hannah Chan; Neil J Oldfield; Emma Newton; Xilian Bai; Jack Aidley; Rory Care; Claire Mattick; David P J Turner; Keith R Neal; Dlawer A A Ala'aldeen; Ian Feavers; Ray Borrow; Christopher D Bayliss
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

4.  Human immune response to meningococcal outer membrane protein epitopes after natural infection or vaccination.

Authors:  R E Mandrell; W D Zollinger
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

5.  Functional activity of antibodies against the recombinant OpaJ protein from Neisseria meningitidis.

Authors:  M I de Jonge; G Vidarsson; H H van Dijken; P Hoogerhout; L van Alphen; J Dankert; P van der Ley
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

6.  Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine.

Authors:  Wendell D Zollinger; Mikhail A Donets; Deborah H Schmiel; Valerian B Pinto; Joseph E Labrie; Elizabeth E Moran; Brenda L Brandt; Boris Ionin; Ryan Marques; Max Wu; Ping Chen; Mark B Stoddard; Paul B Keiser
Journal:  Vaccine       Date:  2010-07-12       Impact factor: 3.641

7.  Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells.

Authors:  M Virji; K Makepeace; D J Ferguson; M Achtman; E R Moxon
Journal:  Mol Microbiol       Date:  1993-11       Impact factor: 3.501

8.  Involvement of genes of genome maintenance in the regulation of phase variation frequencies in Neisseria meningitidis.

Authors:  Patricia Martin; Li Sun; Derek W Hood; E Richard Moxon
Journal:  Microbiology       Date:  2004-09       Impact factor: 2.777

9.  Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis.

Authors:  Vincent E Weynants; Christiane M Feron; Karine K Goraj; Martine P Bos; Philippe A Denoël; Vincent G Verlant; Jan Tommassen; Ian R A Peak; Ralph C Judd; Michael P Jennings; Jan T Poolman
Journal:  Infect Immun       Date:  2007-07-30       Impact factor: 3.441

10.  Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine.

Authors:  Manish Sadarangani; J Claire Hoe; Martin J Callaghan; Claire Jones; Hannah Chan; Katherine Makepeace; Hélène Daniels-Treffandier; Mary E Deadman; Christopher Bayliss; Ian Feavers; Peter van der Ley; Andrew J Pollard
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

View more
  4 in total

1.  The helicase DinG responds to stress due to DNA double strand breaks.

Authors:  Stephan A Frye; Getachew Tesfaye Beyene; Amine Namouchi; Marta Gómez-Muñoz; Håvard Homberset; Shewit Kalayou; Tahira Riaz; Tone Tønjum; Seetha V Balasingham
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

2.  Examination of phase-variable haemoglobin-haptoglobin binding proteins in non-typeable Haemophilus influenzae reveals a diverse distribution of multiple variants.

Authors:  Zachary N Phillips; Amy V Jennison; Paul W Whitby; Terrence L Stull; Megan Staples; John M Atack
Journal:  FEMS Microbiol Lett       Date:  2022-08-01       Impact factor: 2.820

Review 3.  Atypical, Yet Not Infrequent, Infections with Neisseria Species.

Authors:  Maria Victoria Humbert; Myron Christodoulides
Journal:  Pathogens       Date:  2019-12-20

4.  Transmission Dynamics and Microevolution of Neisseria meningitidis During Carriage and Invasive Disease in High School Students in Georgia and Maryland, 2006-2007.

Authors:  Mustapha M Mustapha; Jane W Marsh; Kathleen A Shutt; Jessica Schlackman; Chinelo Ezeonwuka; Monica M Farley; David S Stephens; Xin Wang; Daria Van Tyne; Lee H Harrison
Journal:  J Infect Dis       Date:  2021-06-15       Impact factor: 5.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.